-
1
-
-
84963607000
-
Th17 cell pathway in human immunity
-
Patel DD, Kuchroo VK. Th17 cell pathway in human immunity. Immunity 2015; 43: 1040-1051.
-
(2015)
Immunity
, vol.43
, pp. 1040-1051
-
-
Patel, D.D.1
Kuchroo, V.K.2
-
2
-
-
84975743646
-
IL-17 in chronic inflammation: From discovery to targeting
-
Beringer A, Noack M, Miossec P. IL-17 in chronic inflammation: from discovery to targeting. Trends Mol Med 2016; 22: 230-241.
-
(2016)
Trends Mol Med
, vol.22
, pp. 230-241
-
-
Beringer, A.1
Noack, M.2
Miossec, P.3
-
3
-
-
84904545875
-
Secukinumab in plaque psoriasis-results of two phase 3 trials
-
Langley RG, Elewski BE, Lebwohl M, Reich K, Griffiths CE, Papp K et al. Secukinumab in plaque psoriasis-results of two phase 3 trials. N Engl J Med 2014; 371: 326-338.
-
(2014)
N Engl J Med
, vol.371
, pp. 326-338
-
-
Langley, R.G.1
Elewski, B.E.2
Lebwohl, M.3
Reich, K.4
Griffiths, C.E.5
Papp, K.6
-
4
-
-
84952025973
-
Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis
-
Baeten D, Sieper J, Braun J, Baraliakos X, Dougados M, Emery P et al. Secukinumab, an interleukin-17A inhibitor, in ankylosing spondylitis. N Engl J Med 2015; 373: 2534-2548.
-
(2015)
N Engl J Med
, vol.373
, pp. 2534-2548
-
-
Baeten, D.1
Sieper, J.2
Braun, J.3
Baraliakos, X.4
Dougados, M.5
Emery, P.6
-
5
-
-
78049476708
-
Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments
-
Marodi L, Casanova JL. Primary immunodeficiencies may reveal potential infectious diseases associated with immune-targeting mAb treatments. J Allergy Clin Immunol 2010; 126: 910-917.
-
(2010)
J Allergy Clin Immunol
, vol.126
, pp. 910-917
-
-
Marodi, L.1
Casanova, J.L.2
-
6
-
-
84865793094
-
Immunity to infection in IL-17- deficient mice and humans
-
Cypowyj S, Picard C, Marodi L, Casanova JL, Puel A. Immunity to infection in IL-17- deficient mice and humans. Eur J Immunol 2012; 42: 2246-2254.
-
(2012)
Eur J Immunol
, vol.42
, pp. 2246-2254
-
-
Cypowyj, S.1
Picard, C.2
Marodi, L.3
Casanova, J.L.4
Puel, A.5
-
8
-
-
84971468113
-
Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis
-
Whibley N, Tritto E, Traggiai E, Kolbinger F, Moulin P, Brees D et al. Antibody blockade of IL-17 family cytokines in immunity to acute murine oral mucosal candidiasis. J Leukoc Biol 2016; 99: 1153-1164.
-
(2016)
J Leukoc Biol
, vol.99
, pp. 1153-1164
-
-
Whibley, N.1
Tritto, E.2
Traggiai, E.3
Kolbinger, F.4
Moulin, P.5
Brees, D.6
-
9
-
-
84871061278
-
Mycobacterial diseases and antitumour necrosis factor therapy in USA
-
Winthrop KL, Baxter R, Liu L, Varley CD, Curtis JR, Baddley JW et al. Mycobacterial diseases and antitumour necrosis factor therapy in USA. Ann Rheum Dis 2013; 72: 37-42.
-
(2013)
Ann Rheum Dis
, vol.72
, pp. 37-42
-
-
Winthrop, K.L.1
Baxter, R.2
Liu, L.3
Varley, C.D.4
Curtis, J.R.5
Baddley, J.W.6
-
10
-
-
85014129467
-
Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: A systematic review and meta-analysis
-
Minozzi S, Bonovas S, Lytras T, Pecoraro V, González-Lorenzo M, Bastiampillai AJ et al. Risk of infections using anti-TNF agents in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis: a systematic review and meta-analysis. Expert Opin Drug Saf 2016; 15(Sup1): 11-34.
-
(2016)
Expert Opin Drug Saf
, vol.15
, pp. 11-34
-
-
Minozzi, S.1
Bonovas, S.2
Lytras, T.3
Pecoraro, V.4
González-Lorenzo, M.5
Bastiampillai, A.J.6
-
11
-
-
84928362350
-
The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents
-
Ergun T, Seckin D, Baskan Bulbul E, Onsun N, Ozgen Z, Unalan P et al. The risk of tuberculosis in patients with psoriasis treated with anti-tumor necrosis factor agents. Int J Dermatol 2015; 54: 594-599.
-
(2015)
Int J Dermatol
, vol.54
, pp. 594-599
-
-
Ergun, T.1
Seckin, D.2
Baskan Bulbul, E.3
Onsun, N.4
Ozgen, Z.5
Unalan, P.6
-
12
-
-
84987923875
-
Active tuberculosis in psoriasis patients treated with TNF antagonists: A French nationwide retrospective study
-
Guinard E, Bulai Livideanu C, Bathélémy H, Viguier M, Reguiai Z, Richard MA et al. Active tuberculosis in psoriasis patients treated with TNF antagonists: a French nationwide retrospective study. J Eur Acad Dermatol Venereol 2016; 30: 1336-1341.
-
(2016)
J Eur Acad Dermatol Venereol
, vol.30
, pp. 1336-1341
-
-
Guinard, E.1
Bulai Livideanu, C.2
Bathélémy, H.3
Viguier, M.4
Reguiai, Z.5
Richard, M.A.6
-
13
-
-
77953274576
-
How tumour necrosis factor blockers interfere with tuberculosis immunity
-
Harris J, Keane J. How tumour necrosis factor blockers interfere with tuberculosis immunity. Clin Exp Immunol 2010; 161: 1-9.
-
(2010)
Clin Exp Immunol
, vol.161
, pp. 1-9
-
-
Harris, J.1
Keane, J.2
-
14
-
-
84873691650
-
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin
-
Weaver CT, Elson CO, Fouser LA, Kolls JK. The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 2013; 8: 477-512.
-
(2013)
Annu Rev Pathol
, vol.8
, pp. 477-512
-
-
Weaver, C.T.1
Elson, C.O.2
Fouser, L.A.3
Kolls, J.K.4
-
15
-
-
85019901620
-
IL-17+ γδ T cells as kick-starters of inflammation
-
Papotto PH, Ribot JC, Silva-Santos B. IL-17+ γδ T cells as kick-starters of inflammation. Nat Immunol 2017; 18: 604-611.
-
(2017)
Nat Immunol
, vol.18
, pp. 604-611
-
-
Papotto, P.H.1
Ribot, J.C.2
Silva-Santos, B.3
-
16
-
-
85019909348
-
Interleukin 17 is a chief orchestrator of immunity
-
Veldhoen M. Interleukin 17 is a chief orchestrator of immunity. Nat Immunol 2017; 18: 612-621.
-
(2017)
Nat Immunol
, vol.18
, pp. 612-621
-
-
Veldhoen, M.1
-
17
-
-
84966680721
-
Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis
-
van de Kerkhof PC, Griffiths CE, Reich K, Leonardi CL, Blauvelt A, Tsai TF et al. Secukinumab long-term safety experience: a pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis. J Am Acad Dermatol 2016; 75: 83-98.
-
(2016)
J Am Acad Dermatol
, vol.75
, pp. 83-98
-
-
Van De Kerkhof, P.C.1
Griffiths, C.E.2
Reich, K.3
Leonardi, C.L.4
Blauvelt, A.5
Tsai, T.F.6
-
19
-
-
85018735600
-
Interactions between type 1 interferons and the Th17 response in tuberculosis: Lessons learned from autoimmune diseases
-
Mourik BC, Lubberts E, de Steenwinkel JEM, Ottenhoff THM, Leenen PJM. Interactions between type 1 interferons and the Th17 response in tuberculosis: lessons learned from autoimmune diseases. Front Immunol 2017; 8: 294.
-
(2017)
Front Immunol
, vol.8
, pp. 294
-
-
Mourik, B.C.1
Lubberts, E.2
De Steenwinkel, J.E.M.3
Ottenhoff, T.H.M.4
Leenen, P.J.M.5
-
21
-
-
85024485535
-
Yin and yang of interleukin-17 in host immunity to infection
-
Das S, Khader S. Yin and yang of interleukin-17 in host immunity to infection. F1000Research 2017; 6: 741.
-
(2017)
F1000Research
, vol.6
, pp. 741
-
-
Das, S.1
Khader, S.2
-
22
-
-
85019740661
-
The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers
-
Robinson RT, Huppler AR. The Goldilocks model of immune symbiosis with Mycobacteria and Candida colonizers. Cytokine 2017; 97: 49-65.
-
(2017)
Cytokine
, vol.97
, pp. 49-65
-
-
Robinson, R.T.1
Huppler, A.R.2
-
23
-
-
84884788373
-
B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response
-
Kozakiewicz L, Chen Y, Xu J, Wang Y, Dunussi-Joannopoulos K, Ou Q et al. B cells regulate neutrophilia during Mycobacterium tuberculosis infection and BCG vaccination by modulating the interleukin-17 response. PLoS Pathog 2013; 9: e1003472.
-
(2013)
PLoS Pathog
, vol.9
, pp. e1003472
-
-
Kozakiewicz, L.1
Chen, Y.2
Xu, J.3
Wang, Y.4
Dunussi-Joannopoulos, K.5
Ou, Q.6
-
24
-
-
84919360521
-
BCG vaccinationinduced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells
-
Cruz A, Torrado E, Carmona J, Fraga AG, Costa P, Rodrigues F et al. BCG vaccinationinduced long-lasting control of Mycobacterium tuberculosis correlates with the accumulation of a novel population of CD4+IL-17+TNF+IL-2+ T cells. Vaccine 2015; 33: 85-91.
-
(2015)
Vaccine
, vol.33
, pp. 85-91
-
-
Cruz, A.1
Torrado, E.2
Carmona, J.3
Fraga, A.G.4
Costa, P.5
Rodrigues, F.6
-
25
-
-
77958475885
-
Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns
-
Kagina BM, Abel B, Scriba TJ, Hughes EJ, Keyser A, Soares A et al. Specific T cell frequency and cytokine expression profile do not correlate with protection against tuberculosis after bacillus Calmette-Guérin vaccination of newborns. Am J Respir Crit Care Med 2010; 182: 1073-1079.
-
(2010)
Am J Respir Crit Care Med
, vol.182
, pp. 1073-1079
-
-
Kagina, B.M.1
Abel, B.2
Scriba, T.J.3
Hughes, E.J.4
Keyser, A.5
Soares, A.6
-
26
-
-
51049122843
-
Interleukin 17-producing T cells increased in patients with active pulmonary tuberculosis
-
Peng MY, Wang ZH, Yao CY, Jiang LN, Jin QL, Wang J et al. Interleukin 17-producing T cells increased in patients with active pulmonary tuberculosis. Cell Mol Immunol 2008; 5: 203-208.
-
(2008)
Cell Mol Immunol
, vol.5
, pp. 203-208
-
-
Peng, M.Y.1
Wang, Z.H.2
Yao, C.Y.3
Jiang, L.N.4
Jin, Q.L.5
Wang, J.6
-
27
-
-
33750450544
-
Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection
-
Chackerian AA, Chen SJ, Brodie SJ, Mattson JD, McClanahan TK, Kastelein RA et al. Neutralization or absence of the interleukin-23 pathway does not compromise immunity to mycobacterial infection. Infect Immun 2006; 74: 6092-6099.
-
(2006)
Infect Immun
, vol.74
, pp. 6092-6099
-
-
Chackerian, A.A.1
Chen, S.J.2
Brodie, S.J.3
Mattson, J.D.4
McClanahan, T.K.5
Kastelein, R.A.6
-
28
-
-
77952774172
-
Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung
-
Okamoto Yoshida Y, Umemura M, Yahagi A, O'Brien RL, Ikuta K, Kishihara K et al. Essential role of IL-17A in the formation of a mycobacterial infection-induced granuloma in the lung. J Immunol 2010; 184: 4414-4422.
-
(2010)
J Immunol
, vol.184
, pp. 4414-4422
-
-
Okamoto Yoshida, Y.1
Umemura, M.2
Yahagi, A.3
O'Brien, R.L.4
Ikuta, K.5
Kishihara, K.6
-
29
-
-
81455131790
-
IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung
-
Khader SA, Guglani L, Rangel-Moreno J, Gopal R, Junecko BA, Fountain JJ et al. IL-23 is required for long-term control of Mycobacterium tuberculosis and B cell follicle formation in the infected lung. J Immunol 2011; 187: 5402-5407.
-
(2011)
J Immunol
, vol.187
, pp. 5402-5407
-
-
Khader, S.A.1
Guglani, L.2
Rangel-Moreno, J.3
Gopal, R.4
Junecko, B.A.5
Fountain, J.J.6
-
30
-
-
84883784746
-
Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection
-
Freches D, Korf H, Denis O, Havaux X, Huygen K, Romano M. Mice genetically inactivated in interleukin-17A receptor are defective in long-term control of Mycobacterium tuberculosis infection. Immunology 2013; 140: 220-231.
-
(2013)
Immunology
, vol.140
, pp. 220-231
-
-
Freches, D.1
Korf, H.2
Denis, O.3
Havaux, X.4
Huygen, K.5
Romano, M.6
-
31
-
-
84874568830
-
Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study
-
den Hertog AL, de Vos AF, Klatser PR, Anthony RM. Early specific host response associated with starting effective tuberculosis treatment in an infection controlled placebo controlled mouse study. PLoS ONE 2013; 8: e57997.
-
(2013)
PLoS ONE
, vol.8
, pp. e57997
-
-
Den Hertog, A.L.1
De Vos, A.F.2
Klatser, P.R.3
Anthony, R.M.4
-
32
-
-
84901659079
-
Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection
-
Gopal R, Monin L, Slight S, Uche U, Blanchard E, Fallert Junecko BA et al. Unexpected role for IL-17 in protective immunity against hypervirulent Mycobacterium tuberculosis HN878 infection. PLoS Pathog 2014; 10: e1004099.
-
(2014)
PLoS Pathog
, vol.10
, pp. e1004099
-
-
Gopal, R.1
Monin, L.2
Slight, S.3
Uche, U.4
Blanchard, E.5
Fallert Junecko, B.A.6
-
33
-
-
77956399376
-
Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1
-
van de Veerdonk FL, Teirlinck AC, Kleinnijenhuis J, Kullberg BJ, van Crevel R et al. Mycobacterium tuberculosis induces IL-17A responses through TLR4 and dectin-1 and is critically dependent on endogenous IL-1. J Leukoc Biol 2010; 88: 227-232.
-
(2010)
J Leukoc Biol
, vol.88
, pp. 227-232
-
-
Van De Veerdonk, F.L.1
Teirlinck, A.C.2
Kleinnijenhuis, J.3
Kullberg, B.J.4
Van Crevel, R.5
-
34
-
-
84884392061
-
Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype
-
van Laarhoven A, Mandemakers JJ, Kleinnijenhuis J, Enaimi M, Lachmandas E, Joosten LA et al. Low induction of proinflammatory cytokines parallels evolutionary success of modern strains within the Mycobacterium tuberculosis Beijing genotype. Infect Immun 2013; 81: 3750-3756.
-
(2013)
Infect Immun
, vol.81
, pp. 3750-3756
-
-
Van Laarhoven, A.1
Mandemakers, J.J.2
Kleinnijenhuis, J.3
Enaimi, M.4
Lachmandas, E.5
Joosten, L.A.6
-
35
-
-
84981273184
-
Dissecting host factors that regulate the early stages of tuberculosis infection
-
Agrawal N, Bhattacharyya C, Mukherjee A, Ullah U, Pandit B, Rao KV et al. Dissecting host factors that regulate the early stages of tuberculosis infection. Tuberculosis (Edinb) 2016; 100: 102-113.
-
(2016)
Tuberculosis (Edinb)
, vol.100
, pp. 102-113
-
-
Agrawal, N.1
Bhattacharyya, C.2
Mukherjee, A.3
Ullah, U.4
Pandit, B.5
Rao, K.V.6
-
36
-
-
84855333428
-
Neutrophils in tuberculosis: Friend or foe?
-
Lowe DM, Redford PS, Wilkinson RJ, O'Garra A, Martineau AR. Neutrophils in tuberculosis: friend or foe? Trends Immunol 2012; 33: 14-25.
-
(2012)
Trends Immunol
, vol.33
, pp. 14-25
-
-
Lowe, D.M.1
Redford, P.S.2
Wilkinson, R.J.3
O'Garra, A.4
Martineau, A.R.5
-
37
-
-
84995922981
-
Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization
-
Segueni N, Tritto E, Bourigault ML, Rose S, Erard F, Le Bert M et al. Controlled Mycobacterium tuberculosis infection in mice under treatment with anti-IL-17A or IL-17F antibodies, in contrast to TNFα neutralization. Sci Rep 2016; 6: 36923.
-
(2016)
Sci Rep
, vol.6
, pp. 36923
-
-
Segueni, N.1
Tritto, E.2
Bourigault, M.L.3
Rose, S.4
Erard, F.5
Le Bert, M.6
-
38
-
-
84872131454
-
Human granuloma in vitro model, for TB dormancy and resuscitation
-
Kapoor N, Pawar S, Sirakova TD, Deb C, Warren WL, Kolattukudy PE. Human granuloma in vitro model, for TB dormancy and resuscitation. PLoS ONE 2013; 8: e53657.
-
(2013)
PLoS ONE
, vol.8
, pp. e53657
-
-
Kapoor, N.1
Pawar, S.2
Sirakova, T.D.3
Deb, C.4
Warren, W.L.5
Kolattukudy, P.E.6
-
39
-
-
67650655950
-
A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipidloaded, drug-tolerant, dormant pathogen
-
Deb C, Lee CM, Dubey VS, Daniel J, Abomoelak B, Sirakova TD et al. A novel in vitro multiple-stress dormancy model for Mycobacterium tuberculosis generates a lipidloaded, drug-tolerant, dormant pathogen. PLoS ONE 2009; 4: e6077.
-
(2009)
PLoS ONE
, vol.4
, pp. e6077
-
-
Deb, C.1
Lee, C.M.2
Dubey, V.S.3
Daniel, J.4
Abomoelak, B.5
Sirakova, T.D.6
-
40
-
-
79959815079
-
Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages
-
Daniel J, Maamar H, Deb C, Sirakova TD, Kolattukudy PE. Mycobacterium tuberculosis uses host triacylglycerol to accumulate lipid droplets and acquires a dormancy-like phenotype in lipid-loaded macrophages. PLoS Pathog 2011; 7: e1002093.
-
(2011)
PLoS Pathog
, vol.7
, pp. e1002093
-
-
Daniel, J.1
Maamar, H.2
Deb, C.3
Sirakova, T.D.4
Kolattukudy, P.E.5
-
41
-
-
84997218090
-
Experimental models of foamy macrophages and approaches for dissecting the mechanisms of lipid accumulation and consumption during dormancy and reactivation of tuberculosis
-
Santucci P, Bouzid F, Smichi N, Poncin I, Kremer L, De Chastellier C et al. Experimental models of foamy macrophages and approaches for dissecting the mechanisms of lipid accumulation and consumption during dormancy and reactivation of tuberculosis. Front Cell Infect Microbiol 2016; 6: 122.
-
(2016)
Front Cell Infect Microbiol
, vol.6
, pp. 122
-
-
Santucci, P.1
Bouzid, F.2
Smichi, N.3
Poncin, I.4
Kremer, L.5
De Chastellier, C.6
-
42
-
-
84982156959
-
Understanding the pathophysiology of the human TB lung granuloma using in vitro granuloma models
-
Bhavanam S, Rayat GR, Keelan M, Kunimoto D, Drews SJ. Understanding the pathophysiology of the human TB lung granuloma using in vitro granuloma models. Future Microbiol 2016; 11: 1073-1089.
-
(2016)
Future Microbiol
, vol.11
, pp. 1073-1089
-
-
Bhavanam, S.1
Rayat, G.R.2
Keelan, M.3
Kunimoto, D.4
Drews, S.J.5
-
43
-
-
84899834072
-
Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: International recommendations
-
Iannone F, Cantini F, Lapadula G. Diagnosis of latent tuberculosis and prevention of reactivation in rheumatic patients receiving biologic therapy: international recommendations. J Rheumatol 2014; 91: 41-46.
-
(2014)
J Rheumatol
, vol.91
, pp. 41-46
-
-
Iannone, F.1
Cantini, F.2
Lapadula, G.3
-
44
-
-
84857120107
-
High incidence of intolerance to tuberculosis chemoprophylaxis
-
Haroon M, Martin U, Devlin J. High incidence of intolerance to tuberculosis chemoprophylaxis. Rheumatol Int 2012; 32: 33-37.
-
(2012)
Rheumatol Int
, vol.32
, pp. 33-37
-
-
Haroon, M.1
Martin, U.2
Devlin, J.3
-
45
-
-
85013677409
-
Updates on the risk factors for latent tuberculosis reactivation and their managements
-
Ai JW, Ruan QL, Liu QH, Zhang WH. Updates on the risk factors for latent tuberculosis reactivation and their managements. Emerg Microbes Infect 2016; 5: e10.
-
(2016)
Emerg Microbes Infect
, vol.5
, pp. e10
-
-
Ai, J.W.1
Ruan, Q.L.2
Liu, Q.H.3
Zhang, W.H.4
-
46
-
-
84875205011
-
Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis
-
Sarathy J, Dartois V, Dick T, Gengenbacher M. Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 2013; 57: 1648-1653.
-
(2013)
Antimicrob Agents Chemother
, vol.57
, pp. 1648-1653
-
-
Sarathy, J.1
Dartois, V.2
Dick, T.3
Gengenbacher, M.4
-
47
-
-
75749099727
-
Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model
-
Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C et al. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum 2010; 62: 340-350.
-
(2010)
Arthritis Rheum
, vol.62
, pp. 340-350
-
-
Lin, P.L.1
Myers, A.2
Smith, L.3
Bigbee, C.4
Bigbee, M.5
Fuhrman, C.6
-
48
-
-
84907199166
-
Latent tuberculosis infection: Myths, models, and molecular mechanisms
-
Dutta NK, Karakousis PC. Latent tuberculosis infection: myths, models, and molecular mechanisms. Microbiol Mol Biol Rev 2014; 78: 343-371.
-
(2014)
Microbiol Mol Biol Rev
, vol.78
, pp. 343-371
-
-
Dutta, N.K.1
Karakousis, P.C.2
-
49
-
-
84975886716
-
Defining dormancy in mycobacterial disease
-
Lipworth S, Hammond RJH, Baron VO, Hu Y, Coates A, Gillespie SH. Defining dormancy in mycobacterial disease. Tuberculosis 2016; 99: 131-142.
-
(2016)
Tuberculosis
, vol.99
, pp. 131-142
-
-
Lipworth, S.1
Hammond, R.J.H.2
Baron, V.O.3
Hu, Y.4
Coates, A.5
Gillespie, S.H.6
-
50
-
-
84992597251
-
Tuberculosis
-
Pai M, Behr MA, Dowdy D, Dheda K, Divangahi M, Boehme CC et al. Tuberculosis. Nat Rev Dis Primers 2016; 2: 16076.
-
(2016)
Nat Rev Dis Primers
, vol.2
, pp. 16076
-
-
Pai, M.1
Behr, M.A.2
Dowdy, D.3
Dheda, K.4
Divangahi, M.5
Boehme, C.C.6
-
51
-
-
84875498895
-
The immune response in tuberculosis
-
O'Garra A, Redford PS, McNab FW, Bloom CI, Wilkinson RJ, Berry MP. The immune response in tuberculosis. Annu Rev Immunol 2013; 31: 475-527.
-
(2013)
Annu Rev Immunol
, vol.31
, pp. 475-527
-
-
O'Garra, A.1
Redford, P.S.2
McNab, F.W.3
Bloom, C.I.4
Wilkinson, R.J.5
Berry, M.P.6
-
52
-
-
84919961490
-
Cell death and autophagy in tuberculosis
-
Moraco AH, Kornfeld H. Cell death and autophagy in tuberculosis. Semin Immunol 2014; 26: 497-511.
-
(2014)
Semin Immunol
, vol.26
, pp. 497-511
-
-
Moraco, A.H.1
Kornfeld, H.2
-
53
-
-
0028979703
-
Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
-
Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ et al. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 1995; 2: 561-572.
-
(1995)
Immunity
, vol.2
, pp. 561-572
-
-
Flynn, J.L.1
Goldstein, M.M.2
Chan, J.3
Triebold, K.J.4
Pfeffer, K.5
Lowenstein, C.J.6
-
54
-
-
46249108568
-
Tuberculous granulomas are hypoxic in Guinea pigs, rabbits, and nonhuman primates
-
Via LE, Lin PL, Ray SM, Carrillo J, Allen SS, Eum SY et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 2008; 76: 2333-2340.
-
(2008)
Infect Immun
, vol.76
, pp. 2333-2340
-
-
Via, L.E.1
Lin, P.L.2
Ray, S.M.3
Carrillo, J.4
Allen, S.S.5
Eum, S.Y.6
-
55
-
-
84924213096
-
Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model
-
Guirado E, Mbawuike U, Keiser TL, Arcos J, Azad AK, Wang SH et al. Characterization of host and microbial determinants in individuals with latent tuberculosis infection using a human granuloma model. mBio 2015; 6: e02537-14.
-
(2015)
MBio
, vol.6
, pp. e02537-e02614
-
-
Guirado, E.1
Mbawuike, U.2
Keiser, T.L.3
Arcos, J.4
Azad, A.K.5
Wang, S.H.6
-
56
-
-
84939218936
-
Mycobacterium tuberculosisinduced polarization of human macrophage orchestrates the formation and development of tuberculous granulomas in vitro
-
Huang Z, Luo Q, Guo Y, Chen J, Xiong G, Peng Y et al. Mycobacterium tuberculosisinduced polarization of human macrophage orchestrates the formation and development of tuberculous granulomas in vitro. PLoS ONE 2015; 10: e0129744.
-
(2015)
PLoS ONE
, vol.10
, pp. e0129744
-
-
Huang, Z.1
Luo, Q.2
Guo, Y.3
Chen, J.4
Xiong, G.5
Peng, Y.6
-
57
-
-
84907064892
-
How sisters grow apart: Mycobacterial growth and division
-
Kieser KJ, Rubin EJ. How sisters grow apart: mycobacterial growth and division. Nat Rev Microbiol 2014; 12: 550-562.
-
(2014)
Nat Rev Microbiol
, vol.12
, pp. 550-562
-
-
Kieser, K.J.1
Rubin, E.J.2
-
59
-
-
84893022133
-
Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology
-
Bourigault ML, Vacher R, Rose S, Olleros ML, Janssens JP, Quesniaux VF et al. Tumor necrosis factor neutralization combined with chemotherapy enhances Mycobacterium tuberculosis clearance and reduces lung pathology. Am J. Clin Exp Immunol 2013; 2: 124-134.
-
(2013)
Am J. Clin Exp Immunol
, vol.2
, pp. 124-134
-
-
Bourigault, M.L.1
Vacher, R.2
Rose, S.3
Olleros, M.L.4
Janssens, J.P.5
Quesniaux, V.F.6
-
60
-
-
84946550863
-
IL-17A promotes intracellular growth of Mycobacterium by inhibiting apoptosis of infected macrophages
-
Cruz A, Ludovico P, Torrado E, Gama JB, Sousa J, Gaifem J et al. IL-17A promotes intracellular growth of Mycobacterium by inhibiting apoptosis of infected macrophages. Front Immunol 2015; 6: 498.
-
(2015)
Front Immunol
, vol.6
, pp. 498
-
-
Cruz, A.1
Ludovico, P.2
Torrado, E.3
Gama, J.B.4
Sousa, J.5
Gaifem, J.6
-
61
-
-
84923842431
-
Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and antiinflammatory cytokines is associated with sterilization
-
Gideon HP, Phuah J, Myers AJ, Bryson BD, Rodgers MA, Coleman MT et al. Variability in tuberculosis granuloma T cell responses exists, but a balance of pro- and antiinflammatory cytokines is associated with sterilization. PLoS Pathog 2015; 11: e1004603.
-
(2015)
PLoS Pathog
, vol.11
, pp. e1004603
-
-
Gideon, H.P.1
Phuah, J.2
Myers, A.J.3
Bryson, B.D.4
Rodgers, M.A.5
Coleman, M.T.6
-
62
-
-
85008482368
-
Interleukin 32: A novel player in the control of infectious diseases
-
Ribeiro-Dias F, Saar Gomes R, de Lima Silva LL, Dos Santos JC, Joosten LA. Interleukin 32: a novel player in the control of infectious diseases. J Leukoc Biol 2017; 101: 39-52.
-
(2017)
J Leukoc Biol
, vol.101
, pp. 39-52
-
-
Ribeiro-Dias, F.1
Saar Gomes, R.2
De Lima Silva, L.L.3
Dos Santos, J.C.4
Joosten, L.A.5
-
63
-
-
84928410666
-
Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis
-
Bai X, Shang S, Henao-Tamayo M, Basaraba RJ, Ovrutsky AR, Matsuda JL et al. Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis. Proc Natl Acad Sci USA 2015; 112: 5111-5116.
-
(2015)
Proc Natl Acad Sci USA
, vol.112
, pp. 5111-5116
-
-
Bai, X.1
Shang, S.2
Henao-Tamayo, M.3
Basaraba, R.J.4
Ovrutsky, A.R.5
Matsuda, J.L.6
-
64
-
-
84992497952
-
Helminth-tuberculosis co-infection: An immunologic perspective
-
Babu S, Nutman TB. Helminth-tuberculosis co-infection: an immunologic perspective. Trends Immunol 2016; 37: 597-607.
-
(2016)
Trends Immunol
, vol.37
, pp. 597-607
-
-
Babu, S.1
Nutman, T.B.2
-
65
-
-
77950852658
-
Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: A metaanalysis
-
Diel R, Loddenkemper R, Nienhaus A. Evidence-based comparison of commercial interferon-gamma release assays for detecting active TB: a metaanalysis. Chest 2010; 137: 952-968.
-
(2010)
Chest
, vol.137
, pp. 952-968
-
-
Diel, R.1
Loddenkemper, R.2
Nienhaus, A.3
|